160 related articles for article (PubMed ID: 3079055)
1. Place of antilymphocyte globulins in the immunosuppressive regimen for kidney transplantation.
Touraine JL; Lefrançois N; Dubernard JM; Garnier JL; Eygonnet JP; Gibelin N; Bétuel H; Traeger J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1881. PubMed ID: 3079055
[No Abstract] [Full Text] [Related]
2. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
[No Abstract] [Full Text] [Related]
3. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
Simonton SC; Sibley RK; Fryd DS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
[No Abstract] [Full Text] [Related]
4. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
[No Abstract] [Full Text] [Related]
5. Cyclosporine immunosuppression and perfusion preservation of cadaver kidneys.
Bradley JW; Cho SI; Cosimi AB; Monaco AP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2104-5. PubMed ID: 3079072
[No Abstract] [Full Text] [Related]
6. Quality of life on cyclosporine versus conventional therapy.
Simmons RG; Abress LK
Transplant Proc; 1987 Feb; 19(1 Pt 3):1860-1. PubMed ID: 3079053
[No Abstract] [Full Text] [Related]
7. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT
Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
[No Abstract] [Full Text] [Related]
8. A comparison of three immunosuppressive protocols in patients aged over 50 years.
Fryd DS; So SK; Kruse L; Canafax DM; Sutherland DE; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1530-1. PubMed ID: 3274374
[No Abstract] [Full Text] [Related]
9. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
[No Abstract] [Full Text] [Related]
10. An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping.
Stuart FP; Stuart JK; Thistlethwaite JR; Gaber AO; Mayes J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1959-60. PubMed ID: 3152656
[No Abstract] [Full Text] [Related]
11. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry ML; Ferguson RM
Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
[No Abstract] [Full Text] [Related]
12. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
[No Abstract] [Full Text] [Related]
13. Comparison of three immunosuppressive regimens in high-risk patients: immunologic aspects.
Renna Molajoni E; Bachetoni A; Cinti P; Sallustio F; Rossi M; Pretagostini R; Orlandini A; Berloco P; Alfani D; Cortesini R
Transplant Proc; 1987 Feb; 19(1 Pt 3):1978-80. PubMed ID: 3079064
[No Abstract] [Full Text] [Related]
14. Quadruple therapy for cadaver renal transplantation.
Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
[No Abstract] [Full Text] [Related]
15. Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine.
Schulak JA; Moritz CE; Hricik DE
Transplant Proc; 1989 Feb; 21(1 Pt 2):1709-11. PubMed ID: 2652560
[No Abstract] [Full Text] [Related]
16. Clinical usefulness of conventional fine needle aspiration cytology in kidney transplantation--influence of different immunosuppressive protocols.
Almirall J; Sole M; Campistol JM; Muntane J; Bru C; Oppenheimer F; Andreu J; Revert L
Transplant Proc; 1992 Feb; 24(1):71-2. PubMed ID: 1539350
[No Abstract] [Full Text] [Related]
17. Quadruple-drug induction therapy in combined renal and pancreatic transplantation--OKT3 versus ATG.
Illner WD; Theodorakis J; Abendroth D; Schleibner S; Stangl M; Landgraf R; Land W
Transplant Proc; 1990 Aug; 22(4):1586-7. PubMed ID: 2117795
[No Abstract] [Full Text] [Related]
18. Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution.
Gruber SA; Chavers B; Payne WD; Fryd DS; Canafax DM; Simmons RL; Najarian JS; Matas A
Transplant Proc; 1989 Feb; 21(1 Pt 2):2139-40. PubMed ID: 2652690
[No Abstract] [Full Text] [Related]
19. Two-year fate of 100 kidney transplants treated with low-dose cyclosporine without biopsy guidelines.
Civati G; Del Favero E; Brando B; Broggi ML; Busnach G; Forti D; Belli L; Minetti L
Transplant Proc; 1987 Feb; 19(1 Pt 3):1856-7. PubMed ID: 3079051
[No Abstract] [Full Text] [Related]
20. The results of renal transplantation with cyclosporine in immunologically high-risk patients.
Dickerman RM; Vergne-Marini P; Langley J; Trevino G; Velez R; Brinker K; Nesser D; Long D; Hull AR
Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047
[No Abstract] [Full Text] [Related]
[Next] [New Search]
